POM121
Basic information
Region (hg38): 7:72879349-72951440
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POM121 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 92 | 104 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 0 | |||||
Total | 0 | 0 | 92 | 12 | 5 |
Variants in POM121
This is a list of pathogenic ClinVar variants found in the POM121 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-72925128-C-T | Likely benign (Dec 01, 2022) | |||
7-72926426-C-G | not specified | Uncertain significance (Nov 30, 2022) | ||
7-72926432-C-G | not specified | Uncertain significance (Dec 21, 2023) | ||
7-72926449-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
7-72926463-T-G | not specified | Likely benign (Jun 29, 2022) | ||
7-72926848-G-A | not specified | Uncertain significance (May 24, 2024) | ||
7-72926860-T-C | not specified | Uncertain significance (Jul 12, 2022) | ||
7-72926923-G-A | not specified | Uncertain significance (Feb 11, 2022) | ||
7-72926928-C-A | not specified | Uncertain significance (Nov 21, 2024) | ||
7-72926937-C-A | not specified | Uncertain significance (Sep 24, 2024) | ||
7-72926943-T-A | not specified | Uncertain significance (Dec 05, 2022) | ||
7-72926960-G-T | not specified | Uncertain significance (Jun 09, 2022) | ||
7-72928385-G-A | not specified | Likely benign (Mar 07, 2024) | ||
7-72928387-G-A | not specified | Uncertain significance (Nov 08, 2024) | ||
7-72928450-C-A | not specified | Uncertain significance (Feb 28, 2024) | ||
7-72929945-G-C | not specified | Uncertain significance (Feb 03, 2022) | ||
7-72929969-C-G | not specified | Uncertain significance (Dec 11, 2024) | ||
7-72929969-C-T | not specified | Uncertain significance (Oct 25, 2024) | ||
7-72930023-C-G | not specified | Uncertain significance (Oct 26, 2021) | ||
7-72930034-G-A | not specified | Likely benign (Dec 12, 2024) | ||
7-72930061-A-G | not specified | Uncertain significance (Mar 07, 2024) | ||
7-72938593-T-C | not specified | Uncertain significance (Mar 19, 2024) | ||
7-72938609-C-T | not specified | Uncertain significance (Jan 08, 2025) | ||
7-72938635-G-A | not specified | Uncertain significance (Aug 19, 2024) | ||
7-72938644-C-T | not specified | Uncertain significance (Dec 30, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POM121 | protein_coding | protein_coding | ENST00000395270 | 12 | 72044 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0580 | 0.942 | 125718 | 0 | 30 | 125748 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.975 | 536 | 476 | 1.13 | 0.0000281 | 6274 |
Missense in Polyphen | 129 | 132.26 | 0.97538 | 1948 | ||
Synonymous | -2.72 | 262 | 212 | 1.24 | 0.0000148 | 2207 |
Loss of Function | 3.33 | 7 | 25.0 | 0.280 | 0.00000129 | 341 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.000111 | 0.0000992 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000134 | 0.000132 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000230 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Essential component of the nuclear pore complex (NPC). The repeat-containing domain may be involved in anchoring components of the pore complex to the pore membrane. When overexpressed in cells induces the formation of cytoplasmic annulate lamellae (AL). {ECO:0000269|PubMed:17900573}.;
- Pathway
- RNA transport - Homo sapiens (human);miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in squamous cell - TarBase;tRNA processing;Disease;Gene expression (Transcription);Regulation of HSF1-mediated heat shock response;Metabolism of carbohydrates;Rev-mediated nuclear export of HIV RNA;Late Phase of HIV Life Cycle;HIV Life Cycle;Interactions of Rev with host cellular proteins;Host Interactions of HIV factors;HIV Infection;snRNP Assembly;Vpr-mediated nuclear import of PICs;SUMOylation of DNA damage response and repair proteins;Transport of Ribonucleoproteins into the Host Nucleus;Viral Messenger RNA Synthesis;Export of Viral Ribonucleoproteins from Nucleus;SUMOylation of chromatin organization proteins;Influenza Viral RNA Transcription and Replication;Cellular responses to stress;SUMOylation of RNA binding proteins;Post-translational protein modification;SUMOylation of DNA replication proteins;SUMO E3 ligases SUMOylate target proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Metabolism of proteins;Influenza Life Cycle;Influenza Infection;Metabolism of RNA;Infectious disease;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;SUMOylation;Cellular responses to external stimuli;Regulation of Glucokinase by Glucokinase Regulatory Protein;Glycolysis;Nuclear Pore Complex (NPC) Disassembly;tRNA processing in the nucleus;Transport of Mature mRNA derived from an Intron-Containing Transcript;Metabolism of non-coding RNA;Cellular response to heat stress;Nuclear Envelope Breakdown;Mitotic Prophase;M Phase;Nuclear import of Rev protein;Glucose metabolism;Transcriptional regulation by small RNAs;Cell Cycle;Interactions of Vpr with host cellular proteins;Cell Cycle, Mitotic;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Gene Silencing by RNA
(Consensus)
Recessive Scores
- pRec
- 0.0865
Intolerance Scores
- loftool
- 0.510
- rvis_EVS
- -0.33
- rvis_percentile_EVS
- 30.82
Haploinsufficiency Scores
- pHI
- 0.226
- hipred
- hipred_score
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.268
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pom121
- Phenotype
Gene ontology
- Biological process
- mRNA export from nucleus;protein import into nucleus;viral process
- Cellular component
- nuclear envelope;nuclear pore;nucleoplasm;endoplasmic reticulum membrane;integral component of membrane;nuclear membrane
- Molecular function
- protein binding;nuclear localization sequence binding;structural constituent of nuclear pore